Medicine ❯ Pharmacology ❯ Weight Loss and Diabetes Drugs ❯ GLP-1 Receptor Agonists
The Danish pharmaceutical giant's experimental drug, amycretin, demonstrates significant weight loss in early trials, potentially outperforming its predecessors, Wegovy and Ozempic.